Dechert advised Select Medical Holdings Corporation and Concentra Group Holdings Parent, Inc. on the transaction, while Latham & Watkins advised the underwriters. Medical Holdings Corporation (“Select...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised IO Biotech, and Latham & Watkins advised the placement agents. IO Biotech, Inc. (Nasdaq: IOBT) announced that it has entered into a definitive...
You must be a Standard 1 Year member to access this content.
Herzog Fox & Neeman and Latham & Watkins LLP are advising ODDITY Tech Ltd., while Davis Polk & Wardwell and Goldfarb Gross Seligman & Co. are...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented AlloVir, and Latham & Watkins represented the underwriters in the offering. AlloVir, Inc. (Nasdaq: ALVR) announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin represented RadNet, and Latham & Watkins represented the underwriters. RadNet, Inc. (NASDAQ: RDNT) has announced the closing of its underwritten public offering of 8,711,250 shares...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and operator of out-of-home waxing services...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the IPO while Goodwin advised PepGen. PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with...
You must be a Standard 1 Year member to access this content.
DLA Piper represented Liquidia, while Latham & Watkins represented the underwriters in the offering. Liquidia Corporation, a biopharmaceutical company focused on the development and commercialization of...
You must be a Standard 1 Year member to access this content.
